Why is Shukra Pharma. falling/rising?

As of 04-Sep, Shukra Pharmaceuticals Ltd is experiencing a price increase, currently at Rs. 28.36, reflecting a rise of 0.55 or 1.98%. The stock has recently hit a new 52-week high and has been on a consecutive gain streak for the last 13 days, accumulating a remarkable 57.99% return during this period. Additionally, the stock has demonstrated strong performance over various time frames, with a year-to-date increase of 107.96% and a staggering 335.97% return over the past year, significantly outperforming the BSE500 index. The company's low Debt to EBITDA ratio of 1.28 times and an annual operating profit growth rate of 62.04% further bolster investor confidence, contributing to the stock's upward movement.
In the broader market context, Shukra Pharmaceuticals has outperformed the Sensex, which has only increased by 0.80% over the past week, while Shukra's stock surged by 10.31% in the same timeframe. This trend of outperformance is consistent, as the stock has shown substantial gains compared to the benchmark over the last month and year. However, it is worth noting that there has been a decline in investor participation, with delivery volume dropping by 53.44% against the 5-day average, which may indicate a potential concern for future trading activity. Despite this, the overall strong returns and healthy financial metrics suggest that the stock's rise is supported by solid fundamentals.